Insulin aspart (Jilin Jinsheng)
门冬胰岛素30注射液（吉林津升）
Report date: 2026/03/27 20:01:50
Base Information
Drug NameInsulin aspart (Jilin Jinsheng)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJilin Jinsheng Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJilin Jinsheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A